Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/18354
Title: | The kidney in congestive heart failure: ‘are natriuresis, sodium and diuretics really the good, the bad and the ugly?’ | Authors: | VERBRUGGE, Frederik DUPONT, Matthias STEELS, Paul GRIETEN, Lars SWENNEN, Quirine Tang, W.H. MULLENS, Wilfried |
Issue Date: | 2014 | Source: | European journal of heart failure, 16 (2), p. 133-142 | Abstract: | This review discusses renal sodium handling in heart failure. Increased sodium avidity and tendency to extracellular volume overload, i.e. congestion, are hallmark features of the heart failure syndrome. Particularly in the case of concomitant renal dysfunction, the kidneys often fail to elicit potent natriuresis. Yet, assessment of renal function is generally performed by measuring serum creatinine, which has inherent limitations as a biomarker for the glomerular filtration rate (GFR). Moreover, glomerular filtration only represents part of the nephron’s function. Alterations in the fractional reabsorptive rate of sodium are at least equally important in emerging therapy-refractory congestion. Indeed, renal blood flow decreases before the GFR is affected in congestive heart failure. The resulting increased filtration fraction changes Starling forces in peritubular capillaries, which drive sodium reabsorption in the proximal tubules. Congestion further stimulates this process by augmenting renal lymph flow. Consequently, fractional sodium reabsorption in the proximal tubules is significantly increased, limiting sodium delivery to the distal nephron. Orthosympathetic activation probably plays a pivotal role in those deranged intrarenal haemodynamics, which ultimately enhance diuretic resistance, stimulate neurohumoral activation with aldosterone breakthrough, and compromise the counter-regulatory function of natriuretic peptides. Recent evidence even suggests that intrinsic renal derangements might impair natriuresis early on, before clinical congestion or neurohumoral activation are evident. This represents a paradigm shift in heart failure pathophysiology, as it suggests that renal dysfunction—although not by conventional GFR measurements—is driving disease progression. In this respect, a better understanding of renal sodium handling in congestive heart failure is crucial to achieve more tailored decongestive therapy, while preserving renal function. | Keywords: | congestive heart failure; diuretics; kidney; natriuretic peptides; sodium | Document URI: | http://hdl.handle.net/1942/18354 | ISSN: | 1388-9842 | e-ISSN: | 1879-0844 | DOI: | 10.1002/ejhf.35 | ISI #: | 000337628500004 | Rights: | © 2013 The Authors European Journal of Heart Failure © 2013 European Society of Cardiology | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2015 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Verbrugge_et_al-2014-European_Journal_of_Heart_Failure.pdf Restricted Access | 291.8 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
63
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
112
checked on Apr 23, 2024
Page view(s)
90
checked on Jun 17, 2022
Download(s)
78
checked on Jun 17, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.